February 4, 2023


Grand Défi Ou Goulot D’étranglement Ultime: A French Pharma Tackles Data Science

Most biopharma companies have started down the path of digital transformation – a fundamental overhaul of everything they do for the digital age. It’s not clear yet that anyone has arrived at the desired destination. Even so, there have been some early wins, generally related to operations, as the CEOs of both Novartis and Lilly have described. Arguably, the most...
Read More